Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Victor Vogel
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Concepts & Ideas
Physiology
Procedures
Genes & Molecular Sequences
Sign-in to see full Profile
Network (preview)
10
Wolmark, Norman
9
Costantino, Joseph
8
Wickerham, Lawrence
5
Sereika, Susan
5
Cronin, Walter
5
Rastogi, Priya
4
Geyer, Charles
4
Mamounas, Eleftherios
4
Brufsky, Adam
3
Ryan, Christopher
3
Dakhil, Shaker
3
Fehrenbacher, Louis
3
Ganz, Patricia
3
Rubinstein, Wendy
3
Pajon, Eduardo
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Victor Vogel (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Vogel Victor G
The NSABP Study of Tamoxifen and Raloxifene (STAR) trial.
Expert review of anticancer therapy 2009;9(1):51-60.
-
2009: Wickerham D Lawrence; Costantino Joseph P; Vogel Victor G; Cronin Walter M; Cecchini Reena S; Ford Leslie G; Wolmark Norman
The use of tamoxifen and raloxifene for the prevention of breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2009;181():113-9.
-
2008: Vogel Victor G
Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.
Menopause (New York, N.Y.) 2008;15(4 Suppl):782-9.
-
2008: Vogel Victor G
Managing the risk of breast cancer in postmenopausal women: introduction.
Menopause (New York, N.Y.) 2008;15(4 Suppl):779-81.
-
2008: Greenspan Susan L; Brufsky Adam; Lembersky Barry C; Bhattacharya Rajib; Vujevich Karen T; Perera Subashan; Sereika Susan M; Vogel Victor G
Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2644-52.
-
2008: Vogel Victor G
Preventing breast cancer in high-risk women, 2008.
Oncology (Williston Park, N.Y.) 2008;22(6):666-73; discussion 679, 682, 684.
-
2008: Bender Catherine M; Pacella Maria L; Sereika Susan M; Brufsky Adam M; Vogel Victor G; Rastogi Priya; Casillo Frances E; Richey Susan M; Ryan Christopher M
What do perceived cognitive problems reflect?
The journal of supportive oncology 2008;6(5):238-42.
-
2008: Mamounas Eleftherios P; Jeong Jong-Hyeon; Wickerham D Lawrence; Smith Roy E; Ganz Patricia A; Land Stephanie R; Eisen Andrea; Fehrenbacher Louis; Farrar William B; Atkins James N; Pajon Eduardo R; Vogel Victor G; Kroener Joan F; Hutchins Laura F; Robidoux André; Hoehn James L; Ingle James N; Geyer Charles E; Costantino Joseph P; Wolmark Norman
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1965-71.
-
2008: Hudson Alana G; Gierach Gretchen L; Modugno Francesmary; Simpson Jennifer; Wilson John W; Evans Rhobert W; Vogel Victor G; Weissfeld Joel L
Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(3):680-7.
-
2008: Rastogi Priya; Anderson Stewart J; Bear Harry D; Geyer Charles E; Kahlenberg Morton S; Robidoux André; Margolese Richard G; Hoehn James L; Vogel Victor G; Dakhil Shaker R; Tamkus Deimante; King Karen M; Pajon Eduardo R; Wright Mary Johanna; Robert Jean; Paik Soonmyung; Mamounas Eleftherios P; Wolmark Norman
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):778-85.
-
2008: Reeder Jennifer G; Vogel Victor G
Breast cancer prevention.
Cancer treatment and research 2008;141():149-64.
-
2007: Reeder Jennifer G; Vogel Victor G
Breast cancer risk management.
Clinical breast cancer 2007;7(11):833-40.
-
2007: Bender Catherine M; Sereika Susan M; Brufsky Adam M; Ryan Christopher M; Vogel Victor G; Rastogi Priya; Cohen Susan M; Casillo Frances E; Berga Sarah L
Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.
Menopause (New York, N.Y.) 2007;14(6):995-8.
-
2007: Vogel Victor G
Ontology, oncology, and preventive economies: developing drugs for cancer prevention.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5227-8.
-
2007: Newman Lisa A; Vogel Victor G
Breast cancer risk assessment and risk reduction.
The Surgical clinics of North America 2007;87(2):307-16, vii-viii.
-
2007: Vogel Victor G
Chemoprevention strategies 2006.
Current treatment options in oncology 2007;8(1):74-88.
-
2007: Greenspan Susan L; Bhattacharya Rajib K; Sereika Susan M; Brufsky Adam; Vogel Victor G
Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial.
The Journal of clinical endocrinology and metabolism 2007;92(1):131-6.
-
2006: Vogel Victor G
Recent results from clinical trials using SERMs to reduce the risk of breast cancer.
Annals of the New York Academy of Sciences 2006;1089():127-42.
-
2006: Soran Atilla; D'Angelo Gina; Begovic Mirsada; Ardic Figen; Harlak Ali; Samuel Wieand H; Vogel Victor G; Johnson Ronald R
Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?
The breast journal 2006;12(6):536-43.
-
2006: O'Neill Suzanne M; Peters June A; Vogel Victor G; Feingold Eleanor; Rubinstein Wendy S
Referral to cancer genetic counseling: are there stages of readiness?
American journal of medical genetics. Part C, Seminars in medical genetics 2006;142C(4):221-31.
-
2006: Vogel Victor G
Identifying and screening patients at risk of second cancers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(11):2027-32.
-
2006: Khatcheressian James L; Wolff Antonio C; Smith Thomas J; Grunfeld Eva; Muss Hyman B; Vogel Victor G; Halberg Francine; Somerfield Mark R; Davidson Nancy E;
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):5091-7.
-
2006: Land Stephanie R; Wickerham D Lawrence; Costantino Joseph P; Ritter Marcie W; Vogel Victor G; Lee Myoungkeun; Pajon Eduardo R; Wade James L; Dakhil Shaker; Lockhart James B; Wolmark Norman; Ganz Patricia A
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
JAMA : the journal of the American Medical Association 2006;295(23):2742-51.
-
2006: Vogel Victor G; Costantino Joseph P; Wickerham D Lawrence; Cronin Walter M; Cecchini Reena S; Atkins James N; Bevers Therese B; Fehrenbacher Louis; Pajon Eduardo R; Wade James L; Robidoux André; Margolese Richard G; James Joan; Lippman Scott M; Runowicz Carolyn D; Ganz Patricia A; Reis Steven E; McCaskill-Stevens Worta; Ford Leslie G; Jordan V Craig; Wolmark Norman;
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
JAMA : the journal of the American Medical Association 2006;295(23):2727-41.
-
2006: Modugno Francesmary; Ngo Duyen L; Allen Glenn O; Kuller Lewis H; Ness Roberta B; Vogel Victor G; Costantino Joseph P; Cauley Jane A
Breast cancer risk factors and mammographic breast density in women over age 70.
Breast cancer research and treatment 2006;97(2):157-66.
-
2006: Bender Catherine M; Sereika Susan M; Berga Sarah L; Vogel Victor G; Brufsky Adam M; Paraska Karen K; Ryan Christopher M
Cognitive impairment associated with adjuvant therapy in breast cancer.
Psycho-oncology 2006;15(5):422-30.
-
2006: Vogel Victor G; Taioli Emanuela
Have we found the ultimate risk factor for breast cancer?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1791-4.
-
2006: Beattie Mary S; Costantino Joseph P; Cummings Steven R; Wickerham D Lawrence; Vogel Victor G; Dowsett Mitch; Folkerd Elizabeth J; Willett Walter C; Wolmark Norman; Hankinson Susan E
Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Journal of the National Cancer Institute 2006;98(2):110-5.
-
2006: Rubinstein Wendy S; Latimer Jean J; Sumkin Jules H; Huerbin Michelle; Grant Stephen G; Vogel Victor G
Prospective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high-risk women.
BMC women's health 2006;6():10.
-
2005: Vogel Victor G
Can statin therapy reduce the risk of breast cancer?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8553-5.
-
2005: Singh Shivendra V; Zeng Yan; Xiao Dong; Vogel Victor G; Nelson Joel B; Dhir Rajiv; Tripathi Yamini B
Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak.
Molecular cancer therapeutics 2005;4(11):1747-54.
-
2005: Tan-Chiu Elizabeth; Yothers Greg; Romond Edward; Geyer Charles E; Ewer Michael; Keefe Deborah; Shannon Richard P; Swain Sandra M; Brown Ann; Fehrenbacher Louis; Vogel Victor G; Seay Thomas E; Rastogi Priya; Mamounas Eleftherios P; Wolmark Norman; Bryant John
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7811-9.
-
2005: Romond Edward H; Perez Edith A; Bryant John; Suman Vera J; Geyer Charles E; Davidson Nancy E; Tan-Chiu Elizabeth; Martino Silvana; Paik Soonmyung; Kaufman Peter A; Swain Sandra M; Pisansky Thomas M; Fehrenbacher Louis; Kutteh Leila A; Vogel Victor G; Visscher Daniel W; Yothers Greg; Jenkins Robert B; Brown Ann M; Dakhil Shaker R; Mamounas Eleftherios P; Lingle Wilma L; Klein Pamela M; Ingle James N; Wolmark Norman
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
The New England journal of medicine 2005;353(16):1673-84.
-
2005: Atkins James N; Jacobs Samuel A; Wieand H Samuel; Smith Roy E; John William J; Colangelo Linda H; Vogel Victor G; Kuebler J Philip; Cescon Terrence P; Miller Barbara J; Geyer Charles E; Wolmark Norman
Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program.
Clinical colorectal cancer 2005;5(3):181-7.
-
2005: Soran Atilla; Aydin Cengiz; Harlak Ali; Vogel Victor G; Johnson Ronald
Impact of sentinel lymph node biopsy on lymphedema following breast cancer treatment.
The breast journal 2005;11(5):370-1.
-
2005: Latimer Jean J; Rubinstein Wendy S; Johnson Jennifer M; Kanbour-Shakir Amal; Vogel Victor G; Grant Stephen G
Haploinsufficiency for BRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes.
BMC medical genetics 2005;6():26.
-
2005: Kapoor Avina; Vogel Victor G
Prognostic factors for breast cancer and their use in the clinical setting.
Expert review of anticancer therapy 2005;5(2):269-81.
-
2005: Geller Brian A; Vogel Victor G
Chemoprevention of breast cancer in postmenopausal women.
Breast disease 2005;24():79-92.
-
2004: Xiao Dong; Choi Sunga; Johnson Daniel E; Vogel Victor G; Johnson Candace S; Trump Donald L; Lee Yong J; Singh Shivendra V
Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.
Oncogene 2004;23(33):5594-606.
-
2004: Hollingsworth Alan B; Singletary S Eva; Morrow Monica; Francescatti Darius S; O'Shaughnessy Joyce A; Hartman Anne-Renee; Haddad Becky; Schnabel Freya R; Vogel Victor G
Current comprehensive assessment and management of women at increased risk for breast cancer.
American journal of surgery 2004;187(3):349-62.
-
2004: Vogel Victor G
Atypia in the assessment of breast cancer risk: implications for management.
Diagnostic cytopathology 2004;30(3):151-7.
-
2004: Lo Shelly S; Vogel Victor G
Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs).
Best practice & research. Clinical endocrinology & metabolism 2004;18(1):97-111.
-
2004: Thull Darcy L; Vogel Victor G
Recognition and management of hereditary breast cancer syndromes.
The oncologist 2004;9(1):13-24.
-
2003: Vogel Victor G
Management of the high-risk patient.
The Surgical clinics of North America 2003;83(4):733-51.
-
2003: Rastogi Priya; Vogel Victor G
Update on breast cancer prevention.
Oncology (Williston Park, N.Y.) 2003;17(6):799-805; discussion 808-10, 813.
-
2003: Vogel Victor G; Costantino Joseph P; Wickerham D Lawrence; Cronin Walter M
National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1 Pt 2):495S-501S.
-
2002: Vogel Victor G; Costantino Joseph P; Wickerham D Lawrence; Cronin Walter M
Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
Journal of the National Cancer Institute 2002;94(19):1504.
-
2002: Vogel Victor G; Costantino Joseph P; Wickerham D Lawrence; Cronin Walter M; Wolmark Norman
The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.
Clinical breast cancer 2002;3(2):153-9.
-
2002: Vogel Victor G
Prevention in the balance.
The oncologist 2002;7(2):103-5.
-
2001: Vogel V G
Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12 Suppl):4413s-4418s; discussion 4411s-4412s.
-
2001: Vogel V G
Reducing the risk of breast cancer with tamoxifen in women at increased risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(18 Suppl):87S-92S.
-
2001: Costantino J P; Vogel V G
Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials: an alternative view.
Clinical breast cancer 2001;2(1):41-6.
-
2000: Vogel V G
Breast cancer prevention: a review of current evidence.
CA: a cancer journal for clinicians 2000;50(3):156-70.
Sign-in to see more
